The present invention relates to an ophthalmic lens, in particular for sunglasses.
The wearing of sunglasses, in particular in very bright light, is medically highly recommended for protecting long-term vision potential and also for safety reasons, for example when driving.
Specifically, sunglasses form a barrier to UV rays. Many studies have shown that UV rays may cause lesions, inflammations or deteriorations of the cornea, of the crystalline lens or of the retina. In order to prevent these effects and above all a modification of the eye which may reduce long-term vision, people are increasingly encouraged to wear sunglasses to prevent exposure to a too high light intensity.
Furthermore, sunglasses also make it possible to combat glare, which increases safety when driving or during sporting activities.
This is why sunglasses generally sold today block any radiation having a wavelength of less than 400 nm.
However, medical studies in recent years have shown that a wavelength range around 435 nm (±20 nm), also known under the name “bad blue light”, plays an important role, for example in age-related macular degeneration (AMD). This is a process which is cumulative over a lifetime and which becomes troublesome in particular for people over 60 years old.
In order to solve these problems, ophthalmic lenses are known that have filtering properties in the visible blue part of the spectrum between 400 nm and 480 nm.
However, these known ophthalmic lenses are not completely satisfactory in so far as a portion of the “good blue light” between 450 nm and 480 nm is also significantly attenuated, which is detrimental to the visual spectral perception of the sunglasses wearer. Furthermore, a deterioration of the contrast perceived by the user is observed, which may be a safety drawback, in particular for driving.
Documents U.S. Pat. No. 5,149,183, EP 2 602 655, FR 2 990 774, and US 2010/149483 relate to ophthalmic lenses belonging to the state of the art.
The objective of the invention is therefore to propose an improved ophthalmic lens that makes it possible to at least partially solve the drawbacks of the prior art.
For this purpose, one subject of the invention is an ophthalmic lens comprising a substrate, said lens having a transmission spectrum such that:
the mean transmission in the wavelength range between 380 nm inclusive and 780 nm inclusive (meaning within the wavelength range [380 nm; 780 nm]) is less than 60%;
the mean transmission at wavelengths less than or equal to 400 nm is less than 1%, preferably less than 0.5%, very preferably less than 0.1%;
the mean transmission at wavelengths greater than 400 nm inclusive and less than 500 nm inclusive (meaning within the wavelength range [400 nm; 500 nm]) is less than 30% with a transmission minimum of less than 10%, preferably less than 5%, very preferably less than 1% between 425 nm and 445 nm inclusive (meaning within the wavelength range [425 nm; 445 nm]).
Owing to these properties, the ophthalmic lens according to the invention is capable of filtering out the wavelengths corresponding to ultraviolet light, but also the wavelengths corresponding to bad blue light, with great effectiveness, and therefore of protecting the wearer's eye, while preserving the colorimetric characteristics of the lens. Indeed, although cutting out the bad blue light, the lens allows a sufficient transmission of blue light, in particular with respect to the spectrum for perception of colour by the eye. Furthermore, it makes it possible to have a glass with a colour comprising blueish shades since not all the blue light is cut out.
Finally, the ophthalmic lenses intended for sunglasses must meet certain criteria relating to the perception of colours by the wearer. In particular, such lenses must comply with the ISO 12312-1: 2013 and/or ANSI Z80.3-2001 standards which define criteria for the wearing thereof within the context of a vehicle driving activity. Thus the ophthalmic lenses for sunglasses should in particular not modify the perception of the colour of traffic signals.
The ophthalmic lenses according to the invention thus guarantee, by virtue of their transmission spectrum, an excellent protection for a wearer owing to the simultaneous combination of the following factors:
The ophthalmic lens may have one or more of the following features:
the mean transmission in the wavelength range between 400 nm and 500 nm has, for example, a first transmission maximum located between 405 nm and 425 nm.
According to one aspect, the first maximum located between 405 nm and 425 nm is at least six times higher than the transmission of the first transmission minimum.
According to another aspect, the percentage of transmission of the first maximum is at least two times higher than the percentage of transmission of the first minimum, the percentage of transmission of the first maximum having a percentage of transmission being at least the value of transmission of the first transmission minimum increased by a percentage value of 2%.
According to a further aspect the first maximum is in percentage at least 2%, preferentially 4% higher than the percentage of transmission of the first minimum of transmission.
According to one aspect, the first minimum is located at 435 nm with an accuracy of ±5 nm, preferably with an accuracy of ±2 nm.
According to another aspect, the first minimum is an absorption peak with a degree of absorption of greater than 95% and preferably greater than 99.5%.
The absorption peak may have a quarter-height width of 50 nm or less, and a half-height width of 30 nm or less, and a width at two thirds of the height of the absorption peak of 20 nm or less.
According to yet another aspect, the transmission at the first maximum is greater than 1%, preferably greater than 4%.
According to another aspect, the transmission in the wavelength range between 440 nm and 500 nm increases.
The mean transmission between 380 and 780 nm inclusive may be less than 35%, in particular less than 25% and preferably less than 18%.
The mean transmission between 400 nm and 450 nm is, for example, less than the mean transmission between 450 nm and 650 nm and the mean transmission between 450 nm and 650 nm is, for example, less than the mean transmission between 650 nm and 780 nm.
According to another aspect, the ophthalmic lens is suitable for driving according to the ISO 12312-1: 2013 standard.
The ophthalmic lens may comprise a polarizing assembly.
The substrate comprises, for example, a thermoplastic material, in particular polycarbonate.
The invention also relates to a process for optimizing a colour of an ophthalmic lens with a view to conformity with the ISO 12312-1: 2013 standard relative to a given spectrum, in which the transmission of the lens in the range between 405 nm and 425 nm on the one hand and between 440 nm and 450 nm on the other hand is increased and the transmission in the wavelength range between 430 nm and 440 nm is decreased.
Other features and advantages of the invention will appear more clearly on reading the following description, given by way of illustrative and non-limiting example, and from the appended drawings showing:
On all the figures, identical elements bear the same reference numbers.
An example of an embodiment will now be described with reference to the figures.
The following embodiments are examples. Although the description refers to one or more embodiments, this does not necessarily mean that each reference relates to the same embodiment, or that the features apply only to a single embodiment. Simple features of various embodiments may also be combined and/or interchanged to provide other embodiments.
For the mean transmission between two wavelengths λ1 and λ2, the ISO 11664-1 and ISO 11664-2 definitions are, for example, taken into account.
More specifically, the mean transmission may be defined as:
In the present description, the expression «inclusive» is meant to include also the limits or borders that will also belong to the designated range. For example a wavelength between «425 nm and 445 nm inclusive», it is meant that the wavelength range also comprises the border values ([425 nm, 445 nm]). In this way, it is defined a wavelength range from a wavelength superior or equal to 425 nm up to inferior or equal to 445 nm.
This ophthalmic lens 1 is tinted and is for example intended to be used for spectacles, in particular sunglasses. For this, it is only necessary to shape the outer edge 3 to the desired shape of the rim of the frame.
An ophthalmic lens is understood to mean a finished or semi-finished corrective or non-corrective lens, capable of being mounted in a frame, for example a spectacle frame, a mask and a visor.
The solar ophthalmic lens may or may not be tinted, or may have a tint gradient, and it may comprise other solar functions such as a polarizing or photochromic function, alone or in combination.
It may also comprise other additional functions, alone or in combination, from the following non-exhaustive list: impact-resistant, scratch-resistant, abrasion-resistant, anti-reflective, mirror, anti-soiling, anti-fogging and antistatic functions. These additional functions may be produced according to conventional methods (dip coating, vacuum deposition, spin coating, spray coating, etc.).
The tinted ophthalmic lens 1 comprises, for example, a polarizing assembly 5 composed of at least one first layer 7 and one second layer 9 of a thermoplastic or thermosetting material sandwiching a polarizing film 11. Of course, this polarizing assembly 5 with its layers 7, 9 and 11 is optically transparent, that is to say that it lets light pass through.
As can be seen in
By way of example, the polarizing assembly 5 has a thickness e1 of between 0.3 and 1 mm and the third layer forming a substrate 13 has a thickness e2 of between 0.5 and 2 mm.
The polarizing film is, for example, a film of polyvinyl alcohol (PVA) known for its polarizing properties.
For a glasses use, the layer 13 will be the one intended to be closest to the user's eye and the layer 7 will be the one furthest from the user's eye.
As mentioned above, the two layers 7, 9 may be made of a thermoplastic or thermosetting material, and the layer 13 may be made of a thermoplastic material.
As a thermoplastic material, it is possible, for example, to choose from the following group: polymethyl (meth)acrylate, polycarbonate, polycarbonate/polyester blends, polyamide, polyester, cyclic olefin copolymers, polyurethane, polysulphone, TAC (cellulose triacetate) and a combination thereof.
As thermosetting material, it is possible, for example, to use a transparent material such as CAB (cellulose acetate butyrate).
In order to colour the thermoplastic material, it is possible to add pigments or colourants. These may be organic or mineral pigments. Among these, there is in particular the pigment sold under the reference ABS549 by EXCITON (registered trademark) which is a specific absorber of narrow wavelength width.
In the present case, the substrate formed by the layer 13 comprises several colourants, especially ABS549, which cooperate together in order to absorb the light passing through the lens, the lens having a transmission spectrum such that, as is seen in
the mean transmission in the wavelength range between 380 nm inclusive and 780 nm inclusive is less than 60%;
the mean transmission at wavelengths less than or equal to 400 nm is less than 1%, preferably less than 0.5%, very preferably less than 0.1%;
the mean transmission at wavelengths greater than 400 nm inclusive and less than 500 nm inclusive is less than 30% with a transmission minimum denoted by the reference 100 of less than 10%, preferably less than 5%, very preferably less than 1% between 425 nm and 445 nm inclusive.
Furthermore, the transmission at wavelengths between 405 nm and 425 nm which is non-zero has a first transmission maximum denoted by the reference 105 which is at least 100% greater than the transmission at the first transmission minimum 100.
The first maximum 105 is at least six times greater than the transmission of the first transmission minimum 100.
The transmission at the first minimum 100 is less than 5%, preferably less than 0.5% (for the version of the spectrum from
The first minimum 100 is an absorption peak with a degree of absorption of greater than 95% and preferably greater than 99.5%.
In greater detail, the absorption peak 100 has a quarter-height width of 50 nm or less, and a half-height width of 30 nm or less, and a width at two thirds of the height of the absorption peak 100 of 20 nm or less.
The half-height is found at the location where the absorption is half the maximum absorption. The quarter-height is found at the location where the absorption is a quarter of the maximum absorption. The two-thirds height is found at the location where the absorption is two thirds of the maximum absorption.
The first minimum 100 is located at 435 nm with an accuracy of ±5 nm, preferably with an accuracy of ±2 nm. It is therefore seen that the bad blue light is indeed filtered by the lens 1 according to the invention while transmitting at least one portion of the blue wavelengths of the visible light spectrum, which is not harmful for the human eye and can therefore be used for safe vision. It is therefore understood that in this way a lens is obtained that gives better eye protection while resulting in only a small, reduced and in some cases nearly imperceptible deformation of the perception of contrasts and colours.
The transmission at the first maximum 105 is greater than 1%, preferably greater than 4%.
The transmission in the wavelength range between 440 nm and 500 nm increases in particular for the “brown” version from
Depending on the sunglasses category, the mean transmission between 380 and 780 nm inclusive is less than 35%, in particular less than 25% for category 2 and preferably less than 18% for category 3.
For the two examples from
As regards the “brown” version from
As from the colorimetry point of view, the colorimetric characteristics of the colorimetric CIE model may be the following: L between 36.0 and 37.0, in particular 36.83, a between 6.0 and 7.5, in particular 6.91, and b between 18.0 and 19.5, in particular 18.95.
Furthermore, the ophthalmic lens is thus suitable for driving according to the ISO 12312-1: 2013 standard.
However, one may proceed thanks to the invention to an optimization of the colour of such an ophthalmic lens in view of its conformity to the ISO 12312-1: 2013 with respect to the spectrum given in
One may get in this way a lens having a transmittance curve as represented in
It is therefore clearly understood that the ophthalmic lenses according to the invention make it possible to protect the human eye more effectively against bad blue light without the non-harmful portion of the blue light being excessively attenuated.
It is in particular possible to observe in
By the condition that the percentage of transmission of the first maximum 105 is at least two times higher than the percentage of transmission of the first minimum 100, the percentage of transmission of the first maximum 105 having a percentage of transmission being at least the value of transmission of the first transmission minimum increased by a percentage value of 2%, it is meant that if Tmin1 is the value of transmittance of the first transmission minimum 100 and Tmax1 is the value of transmission of the first transmission maximum 105, Tmax1>2*Tmin1 et Tmax1>Tmin1+2%.
By the condition, that the percentage of the first maximum 105 is at least 2%, preferentially 4% higher than the percentage of transmission of the first minimum of transmission 100, it is meant that Tmax1>Tmin1+2%, in particular Tmax1>Tmin1+4%.
According to the example in
In this case, the transmission the first transmission maximum 105 is 10.2 times higher than the transmission of the first transmission minimum 100.
The difference between the transmission of the first transmission maximum 105 and the first transmission minimum is 4.04% (=4.48%-0.44%) and thus the transmission of the first transmission maximum 105 is at least two times higher than the percentage of transmission of the first minimum 100, the percentage of transmission of the first maximum 105 having a percentage of transmission being at least the value of transmission of the first transmission minimum increased by a percentage value of 2% (in this case by 4.04%).
The percentage of the first maximum 105 is thus more than 4% higher than the percentage of transmission of the first minimum of transmission 100.
Other variants are possible without departing from the scope of the present invention. Thus, the substrate, the layer 13 may be shaped to furthermore provide an optical correction to the vision of the user.
The layer 13 may be sandwiched between the polarizing assembly and another layer, for example made of clear or coloured polycarbonate. In this case, it may be the latter layer which is cut/polished in order to provide an optical correction and not the layer 13.
Number | Date | Country | Kind |
---|---|---|---|
15 50796 | Feb 2015 | FR | national |
This application is a continuation application of U.S. patent application Ser. No. 15/012,241 filed on Feb. 1, 2016 entitled “OPHTHALMIC LENS, IN PARTICULAR FOR SUNGLASSES,” which application claims priority to French Application FR1550796 filed Feb. 2, 2015.
Number | Name | Date | Kind |
---|---|---|---|
5149183 | Perrott et al. | Sep 1992 | A |
5413971 | McPherson | May 1995 | A |
5434707 | Dalzell et al. | Jul 1995 | A |
5922246 | Matsushita et al. | Jul 1999 | A |
6177032 | Smith et al. | Jan 2001 | B1 |
6328446 | Bhalakia et al. | Dec 2001 | B1 |
6334680 | Larson | Jan 2002 | B1 |
6650473 | Nakagoshi | Nov 2003 | B2 |
6807006 | Nakagoshi | Oct 2004 | B2 |
8012386 | Clerc | Sep 2011 | B2 |
8733929 | Chiou et al. | May 2014 | B2 |
9229247 | Clerc et al. | Jan 2016 | B2 |
9937676 | Clerc et al. | Apr 2018 | B2 |
9989686 | Clerc et al. | Jun 2018 | B2 |
20020044352 | Yamamoto et al. | Apr 2002 | A1 |
20030052423 | Gross et al. | Mar 2003 | A1 |
20030184863 | Nakagoshi | Oct 2003 | A1 |
20040223221 | Sugimura et al. | Nov 2004 | A1 |
20070076166 | Kobuchi et al. | Apr 2007 | A1 |
20080062378 | McCracken | Mar 2008 | A1 |
20080231795 | Cartier | Sep 2008 | A1 |
20080291394 | Ishak | Nov 2008 | A1 |
20100149483 | Chiavetta, III | Jun 2010 | A1 |
20110063569 | Miyoshi | Mar 2011 | A1 |
20110141432 | Nesty | Jun 2011 | A1 |
20130271725 | Chiou | Oct 2013 | A1 |
20140233105 | Schmeder et al. | Aug 2014 | A1 |
20150160479 | Ohkubo et al. | Jun 2015 | A1 |
20160041408 | Carlson | Feb 2016 | A1 |
20160223838 | Martins et al. | Aug 2016 | A1 |
Number | Date | Country |
---|---|---|
0 940 244 | Sep 1999 | EP |
1 193 044 | Apr 2002 | EP |
1 607 203 | Dec 2005 | EP |
1 804 088 | Jul 2007 | EP |
2 602 655 | Jun 2013 | EP |
2 990 774 | Nov 2013 | FR |
WO 2004059370 | Jul 2004 | WO |
Entry |
---|
U.S. Appl. No. 15/971,068, filed May 4, 2018, Clerc, et al. |
Advisory Action dated Jan. 13, 2017 for U.S. Appl. No. 15/012,241; 4 pages. |
After Final Consideration Pilot Program Request for U.S. Appl. No. 15/012,241, filed Dec. 16, 2016; 2 pages. |
Final Office Action dated Feb. 9, 2018 for U.S. Appl. No. 15/012,241; 9 pages. |
Final Office Action dated Oct. 19, 2016 for U.S. Appl. No. 15/012,241; 18 pages. |
Office Action dated Jul. 27, 2017 for U.S. Appl. No. 15/012,241; 21 pages. |
Office Action dated May 3, 2016 for U.S. Appl. No. 15/012,241; 18 pages. |
Request for Continued Examination (RCE) for U.S. Appl. No. 15/012,241, filed Jan. 19, 2017; 2 pages. |
Response to Final Office Action dated Feb. 9, 2018 for U.S. Appl. No. 15/012,241, filed May 1, 2018; 7 pages. |
Response to Final Office Action dated Oct. 19, 2016 for U.S. Appl. No. 15/012,241, filed Dec. 16, 2016; 12 pages. |
Response to Office Action dated Jul. 27, 2017 for U.S. Appl. No. 15/012,241, filed Nov. 10, 2017; 13 pages. |
Response to Office Action dated May 3, 2016 for U.S. Appl. No. 15/012,241, filed Jul. 20, 2016; 13 pages. |
Supplemental Amendment and Response to Final Office Action and Advisory Action dated Oct. 19, 2016 for U.S. Appl. No. 15/012,241, filed Jan. 19, 2017; 12 pages. |
Supplemental Amendment and Response to Office Action dated May 3, 2016 for U.S. Appl. No. 15/012,241, filed Jul. 21, 2016; 14 pages. |
Notice of Allowance dated Jun. 22, 2018 for U.S. Appl. No. 15/012,241; 7 Pages. |
Notice of Allowance dated Dec. 6, 2017 for U.S. Appl. No. 14/383,229; 10 Pages. |
Office Action dated Aug. 7, 2017 for U.S. Appl. No. 14/383,229; 18 pages. |
Response to Aug. 7, 2017 Office Action for U.S. Appl. No. 14/383,229, filed Oct. 6, 2017; 10 pages. |
Translation of the PCT International Search Report and Written Opinion of the ISA for PCT/EP2013/054666 dated Jun. 3, 2013; 10 pages. |
Amendment Under 37 C.F.R. §1.312 Filed Dec. 3, 2015 for U.S. Appl. No. 14/383,232; 10 pages. |
Notice of Allowance dated Oct. 5, 2015 for U.S. Appl. No. 14/383,232; 12 pages. |
Translation of the PCT International Search Report and Written Opinion of the ISA dated Jun. 5, 2013 for PCT/EP2013/054663; 7 pages. |
Appeal Brief filed Oct. 3, 2017 for U.S. Appl. No. 14/342,927; 33 Pages. |
Final Office Action dated Jun. 17, 2016 for U.S. Appl. No. 14/342,927; 22 Pages. |
Non-Final Office Action dated Jan. 4, 2017 for U.S. Appl. No. 14/342,927; 21 Pages. |
Non-Final Office Action dated Jan. 6, 2016 for U.S. Appl. No. 14/342,927; 13 Pages. |
Notice of Allowance dated Feb. 5, 2018 for U.S. Appl. No. 14/342,927; 10 Pages. |
Notification of Non-Compliant Appeal Brief dated Oct. 24, 2017 for U.S. Appl. No. 14/342,927; 2 Pages. |
Response to Final Office Action dated Jun. 17, 2016 for U.S. Appl. No. 14/342,927; RCE/Response filed Aug. 17, 2016; 12 Pages. |
Response to Non-Final Office Action dated Jan. 6, 2016 for U.S. Appl. No. 14/342,927; Response filed May 5, 2016; 15 Pages. |
Response to Notification of Non-Compliant Appeal Brief dated Oct. 24, 2017 for U.S. Appl. No. 14/342,927; Response filed Nov. 2, 2017; 4 Pages. |
Response to Restriction Requirement dated Sep. 18, 2015 for U.S. Appl. No. 14/342,927; Response filed Nov. 5, 2015; 7 Pages. |
Restriction Requirement dated Sep. 18, 2015 for U.S. Appl. No. 14/342,927; 7 Pages. |
Translation of the PCT International Search Report and Written Opinion of the ISA for PCT/EP2012/067231 dated Oct. 23, 2012; 9 pages. |
Chinese Office Action with English Translations of Chinese Appl. No. 201280054459.9 dated Oct. 30, 2015 and claims as allowed by CPO; 13 pages. |
International Standard; ISO 12312-1; Eye and Face Protection—Sunglasses and Related Eyewear; Part 1—Sunglasses for General Use; ISO 12312-1:2013(E); First Edition; Aug. 2013; Web. Apr. 20, 2016; 4 pages. |
U.S. Non-Final Office Action dated Apr. 30, 2019 for U.S. Appl. No. 15/971,068; 17 Pages. |
Response to U.S. Non-Final Office Action dated Apr. 30, 2019 for U.S. Appl. No. 15/971,068; Response filed Jul. 22, 2019; 15 Pages. |
U.S. Final Office Action dated Aug. 15, 2019 for U.S. Appl. No. 15/971,068; 15 Pages. |
Response to U.S. Final Office Action dated Aug. 15, 2019 for U.S. Appl. No. 15/971,068; Response filed Sep. 16, 2019; 13 pages. |
Number | Date | Country | |
---|---|---|---|
20180373063 A1 | Dec 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15012241 | Feb 2016 | US |
Child | 16115927 | US |